https://doi.org/10.4081/monaldi.2022.2129
The value of supplemental prone imaging in low-dose CT lung cancer screening. A technical note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 14 March 2022
This technical note presents our experience with the additional prone examination of patients during low dose CT lung cancer screening. The prone examination adds only a minor amount of radiation and time to the study and can reduce false positive findings that are gravity-dependent.
Downloads
The National Lung Screening Trial Research Team: Reduced lung-cancer mortality with low-dose computed tomography screening. N Engl J Med 2011;365:395-409. DOI: https://doi.org/10.1056/NEJMoa1102873
De Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT scanning in a randomized trial. N Engl J Med 2020;382:503-13. DOI: https://doi.org/10.1056/NEJMoa1911793
Ebell MH, Bentivegna M, Hulme C. Cancer-specific mortality, all-cause mortality and overdiagnosis in lung cancer screening trials: a meta-analysis. Ann Fam Med 2020;18:545-52. DOI: https://doi.org/10.1370/afm.2582
Kissinger LS, Anderson C, Kim J, et al. Implementation of lung cancer screening in the veterans health administration. J AMA Intern Med 2017;177:399-406.
Chung JH, Richards JC, Koelsch TL, et al. Screening for lung cancer: Incidental pulmonary parenchymal findings. AJR Am J Roentgenol 2018;210:503-13. DOI: https://doi.org/10.2214/AJR.17.19003
Hata A, Schiebler ML, Lynch DA, Hatabu H. Interstitial lung abnormalities: State of the art. Radiology 2021;301:19-34. DOI: https://doi.org/10.1148/radiol.2021204367
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.